Back to Search
JUSTIN FAYE, MD
MD
Pain Medicine Physician
NPI: 1720508880IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pain Medicine PhysicianPrimary
Pain Medicine — Pain Medicine
Code: 208VP0000X
T2366(TX)
CMS Specialties
PrimaryPHYSICAL MEDICINE AND REHABILITATION
Education
OTHER
Class of 2017
Research & Publications (20)
Synthesis and application of a N-1' fluorescent biotinyl derivative inducing the specific carboxy-terminal dual labeling of a novel RhoB-selective scFv.
PMID 19348471·Bioconjug Chem·2009
8-other
Identification of a GTP-bound Rho specific scFv molecular sensor by phage display selection.
PMID 18377644·BMC Biotechnol·2008
8-other
Synthesis of estradiol-pheophorbide a conjugates: evidence of nuclear targeting, DNA damage and improved photodynamic activity in human breast cancer and vascular endothelial cells.
PMID 17077894·Photochem Photobiol Sci·2006
8-other
[Supervision of body composition and cardiovascular parameters in long sprint running athletes (400 m)].
PMID 16924853·Dakar Med·2006
8-other
Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells.
PMID 16539721·BMC Cancer·2006
8-other
[Effects of Ramadan fast on weight, performance and glycemia during training for resistance].
PMID 17632999·Dakar Med·2005
8-other
Prenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity.
PMID 15642170·Breast Cancer Res·2005
8-other
Farnesyl-transferase inhibitor R115,777 enhances tamoxifen inhibition of MCF-7 cell growth through estrogen receptor dependent and independent pathways.
PMID 16457696·Breast Cancer Res·2005
8-other
Geranylgeranyl transferase inhibition stimulates anti-melanoma immune response through MHC Class I and costimulatory molecule expression.
PMID 15990392·FASEB J·2005
7-preclinical
Chemical-based translational induction of luciferase expression: an efficient tool for in vivo screening of protein farnesylation inhibitors.
PMID 15784845·Mol Pharmacol·2005
4-observational
Molecular characterization of the microsomal tamoxifen binding site.
PMID 15175332·J Biol Chem·2004
7-preclinical
A recombinant cell bioassay for measurement of overall estrogenic activity of serum: preliminary results in women with breast cancer.
PMID 15387438·Clin Chem Lab Med·2004
4-observational
Pharmacological-based translational induction of transgene expression in mammalian cells.
PMID 15192697·EMBO Rep·2004
7-preclinical
Induction of T-cell antitumor immunity and protection against tumor growth by secretion of soluble human CD70 molecules.
PMID 15153937·Cancer Gene Ther·2004
7-preclinical
Tamoxifen is a potent inhibitor of cholesterol esterification and prevents the formation of foam cells.
PMID 14617686·J Pharmacol Exp Ther·2004
7-preclinical
Additive effects of tamoxifen and the farnesyl transferase inhibitor FTI-277 on inhibition of MCF-7 breast cancer cell-cycle progression.
PMID 12866041·Int J Cancer·2003
8-other
Cloning of the human RHOB gene promoter: characterization of a VNTR sequence that affects transcriptional activity.
PMID 12706111·Genomics·2003
8-other
[Cohorts and bio-libraries for studying malaria in tropical areas].
PMID 12684576·Rev Epidemiol Sante Publique·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 110 E Savannah Ave Ste 203C
McAllen, TX 78503 - Phone
- (956) 627-6445
Quick Facts
- NPI
- 1720508880
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile